Ascendis Pharma A/S vs Duke Energy Corp — how do they compare? Ascendis Pharma A/S trades at $254.51 (market cap $16.67B), while Duke Energy Corp trades at $123.08 (market cap $96.05B). The key difference: Duke Energy Corp is far larger — about 5.8× Ascendis Pharma A/S's market cap, and Duke Energy Corp pays a 3.52% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DUK | |
|---|---|---|
Market Cap | $16.67B | $96.05B |
Sector | Health | Utilities |
52-Week High | $277.18 | $133.46 |
52-Week Low | $189.74 | $113.99 |
Enterprise Value | $17.04B | $188.56B |
Dividend Yield | — | 3.52% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →